Skip Navigation

Faculty Directory

Ju Nyeong Park, PhD

  • Associate Scientist

Departmental Affiliations

Contact Information

624 N. Broadway
Hampton House 186
Baltimore, Maryland 21205



View Current Courses


PhD, Johns Hopkins Bloomberg School of Public Health, 2018
MHS, Johns Hopkins Bloomberg School of Public Health, 2013
BS, University of Sydney, 2009


Dr. Ju Nyeong Park is an epidemiologist who conducts research on substance use, drug overdose, and infectious diseases. Dr. Park has expertise in the design and implementation of community-based epidemiological studies, survey development, data management and data analysis. Dr. Park currently leads two projects: 1) She is Co-PI of a statewide evaluation of Maryland's overdose response, supported by a Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) through the Maryland Department of Health; 2) She is PI of the Optimizing PrEP Among Women and their Long-Term Partners (OPAL) Study funded through the Center for AIDS Research.

Dr. Park also collaborates on several studies that examine substance use, trauma, and drug treatment. Previously she worked on HIV and HCV projects in the US, Australia and Cameroon among key populations. Dr. Park has provided technical assistance to a variety of health agencies, including the Baltimore City Health Department, Maryland Department of Health and the Maryland Opioid Operational Command Center.

Honors and Awards

2019 NIDA Women & Sex/Gender Differences Junior Investigator Travel Award

2016 Charlotte Silverman Award, Department of Epidemiology, JHBSPH

2013 Conference Travel Award, International AIDS Society, Geneva, Switzerland

2013 Conference Travel Award, Center for Global Health, Johns Hopkins University

2013 Community Service Award, Johns Hopkins Student Outreach Resource Center

  • fentanyl
  • opioid
  • overdose
  • addiction
  • substance use
  • drug use
  • trauma
  • HIV
  • epidemiology
  • community-based research
  • longitudinal data analysis
  • confirmatory factor analysis
  • time location sampling

Selected publications

  • Park JN, Rouhani S, Beletsky L, Vincent L, Saloner B, Sherman SG. Situating the Continuum of Overdose Risk in the Social Determinants of Health: A New Conceptual Framework. Milbank Quarterly. 2020; 98(3):700-746. [Epub ahead of print]. PMID: 32808709.
  • Park JN, Rashidi, E, Foti K, Zoorob M, Sherman SG, Alexander GC. Fentanyl and Fentanyl Analogs in the U.S., Illicit Stimulant Supply: Results from National Drug Seizure Data, 2011-2016. Drug and Alcohol Dependence, Nov 23;218:108416. [Epub ahead of print]
  • Green TC, Park, JN, Gilbert M, McKenzie M, Struth E, Lucas R, Clarke W, Sherman SG. An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples. International Journal of Drug Policy. 2020; 77:102661. [Epub ahead of print]. PMID: 31951925.
  • Park JN, Tomko C, Silberzahn BE, Haney K, Marshall BDL, Sherman SG. A fentanyl test strip intervention to reduce overdose risk among female sex workers who use drugs in Baltimore: Results from a pilot study. Addict Behaviors. 2020; 110:106529. [Epub ahead of print]. PMID: 32683172.
  • Park JN, Footer KHA, Decker MR, Tomko C, Allen ST, Galai N, Sherman SG. Interpersonal and structural factors associated with receptive syringe sharing among a prospective cohort of female sex workers who inject drugs. Addiction. 2019; 114(7):1204-1213. PMID: 30694587.